Survival and Prognostic Factors in Systemic Sclerosis-Associated Pulmonary Hypertension: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Survival and Prognostic Factors in Systemic Sclerosis-Associated Pulmonary Hypertension: A Systematic Review and Meta-Analysis

Published:2013-08-26 Issue:9 Volume:65 Page:2412-2423
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Lefèvre Guillaume¹,Dauchet Luc²,Hachulla Eric¹,Montani David³,Sobanski Vincent¹,Lambert Marc⁴,Hatron Pierre-Yves⁴,Humbert Marc³,Launay David¹

Affiliation:

1. Université Lille Nord de France, IMPRT IFR 114, Hôpital Claude-Huriez, and Centre Hospitalier Régional Universitaire de Lille; Lille France

2. Université Lille Nord de France, Hôpital Calmette, Centre Hospitalier Régional Universitaire de Lille, Institut Pasteur de Lille, and INSERM 744; Lille France

3. Université Paris-Sud, AP-HP, and Hôpital Bicêtre, Le Kremlin-Bicêtre, France, and INSERM U999 and Centre Chirurgical Marie-Lannelongue; Le Plessis-Robinson France

4. Université Lille Nord de France, Hôpital Claude-Huriez, and Centre Hospitalier Régional Universitaire de Lille; Lille France

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.38029/fullpdf

Reference57 articles.

1. Systemic sclerosis-associated pulmonary arterial hypertension;Le Pavec;Am J Respir Crit Care Med,2010

2. Changes in causes of death in systemic sclerosis, 1972-2002;Steen;Ann Rheum Dis,2007

3. Updated clinical classification of pulmonary hypertension;Simonneau;J Am Coll Cardiol,2009

4. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT);Galie;Eur Respir J,2009

5. Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension: a Bayesian approach to evaluating treatment for uncommon disease;Johnson;J Rheumatol,2012

Cited by 209 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can subcutaneous treprostinil be an alternative for treating pulmonary hypertension in patients with systemic sclerosis-related interstitial lung disease?;ARP Rheumatology;2024-06-30

2. Pulmonary arterial hypertension in systemic sclerosis: a national inpatient analysis;ARP Rheumatology;2024-06-30

3. Prognostic value of pulmonary diffusing capacity for carbon monoxide and ventilation–perfusion SPECT findings in pulmonary arterial hypertension;Experimental Physiology;2024-05-09

4. N-terminal pro-brain natriuretic peptide is associated with pulmonary hypertension or diastolic dysfunction in patients with systemic sclerosis: An Australian prospective cross-sectional study;Journal of Scleroderma and Related Disorders;2024-05-09

5. Pulmonary Hypertension in Connective Tissue Diseases;Koşuyolu Heart Journal;2024-04-01